A Randomised Phase II study comparing the efficacy of 5azacitidine alone versus combination therapy with lenalidomide and 5azacitidine in patients with higher risk myelodysplastic syndromes (MDS) and low marrow blast count acute myeloid leukaemia (AML). (MDS04)
收藏DataCite Commons2023-08-31 更新2024-07-13 收录
下载链接：
https://www.allg.org.au/datasets/mds04/
下载链接
链接失效反馈官方服务：
资源简介：
HeSANDA 1.0.0
提供机构：
Australasian Leukaemia and Lymphoma Group (ALLG)
创建时间：
2023-06-08
